Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Growth-stage investor and operator focused on scaling technology companies, with hands-on experience across product, strategy and operations. AMY TEH has led venture and private-equity investments in SaaS, fintech and marketplaces, sits on multiple boards and advises founders on go-to-market and unit economics. Known for active portfolio management, deal sourcing in Southeast Asia and structuring follow-on capital.
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
Growth-stage, hands-on investor focused on scaling technology businesses across SaaS, fintech and marketplaces in Southeast Asia. Prioritises unit-economics-driven go-to-market plays, structured follow-on capital and active board engagement to accelerate product-market fit and durable revenue expansion. Investment style blends operational value-add with disciplined capital allocation, a multi-year growth horizon, selective risk-taking around market-leading founders, and emphasis on repeatable monetisation and scalable distribution channels.
| Trades 928 | Longs Won 428/928 46% | Profit Factor 0.89 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.01M |
| Average Win $229,048.05 | Best Trade (Mar 31) $11.47M | Sharpe Ratio -1.96 |
| Average Loss -$219,296.32 | Worst Trade (Mar 30) -$16.45M | Z-Score -4.14 (100%) |
| Commissions $0 | Avg. Trade Length 3m 4w | Expectancy -$12,516.8 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 14.12B% | 49.73M% | 1.83M% | 175,063.56% | 28,404.22% | 6,427.75% | 1,829.97% | 616.33% | 236.01% |
| Consecutive Losing Trades | 1,536 | 1,382 | 1,229 | 1,075 | 922 | 768 | 614 | 461 | 307 | 154 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 21,826 | $2.9M | $3.85M | - | $946,265.81 | 32.64% | +0.362% |
ABBV AbbVie Inc. | 11,928 | $3M | $3.38M | - | $378,833.08 | 12.62% | -0.028% |
ABCL AbCellera Biologics Inc. | 27,092 | $212,672 | $338,785.46 | - | $126,113.46 | 59.3% | -1.38% |
ABSI Absci Corporation | 19,712 | $228,462 | $174,451.2 | - | -$54,010.8 | -23.64% | -0.338% |
ACAD Acadia Pharmaceuticals Inc. | 28,725 | $726,743 | $563,584.5 | - | -$163,158.5 | -22.45% | -0.457% |
ACHC Acadia Healthcare Company, Inc. | 66,843 | $1.97M | $2.06M | - | $84,890.4 | 4.3% | -0.773% |
ACI Albertsons Companies, Inc. | 18,689 | $252,862 | $244,171.78 | - | -$8,690.22 | -3.44% | +0.307% |
ADPT Adaptive Biotechnologies Corporation | 3,787.25 | $324,946.05 | $96,877.85 | - | -$228,068.2 | -70.19% | -0.156% |
AEP American Electric Power Company, Inc. | 185,962 | $25.44M | $23.11M | - | -$2.33M | -9.15% | -1.459% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 5,293 | $2.56M | $1.54M | - | -$1.02M | -39.81% | -3.721% |
ALMS Alumis Inc. | 15,396 | $359,734 | $94,454.46 | - | -$265,279.54 | -73.74% | -2.773% |
ALNY Alnylam Pharmaceuticals Inc | 5,588 | $1.68M | $1.3M | - | -$380,040.24 | -22.59% | -0.432% |
AMC AMC Entertainment Holdings, Inc. | 37,228 | $70,733 | $110,541.1 | - | $39,808.1 | 56.28% | -1.352% |
ARGX argenx SE American Depositary Receipt | 4,392 | $4.07M | $3.68M | - | -$397,871.44 | -9.76% | -1.074% |
ARWR Arrowhead Pharmaceuticals Inc. | 5,427 | $442,355 | $312,785.14 | - | -$129,569.86 | -29.29% | -1.479% |
AVR Anteris Technologies Ltd. | 39,233 | $386,445 | $247,167.9 | - | -$139,277.1 | -36.04% | -0.943% |
AVTR Avantor Inc. | 131,088 | $1.3M | $2.12M | - | $817,333.88 | 62.98% | +0.28% |
AXSM Axsome Therapeutics, Inc. | 13,831 | $2.34M | $2.22M | - | -$113,414.18 | -4.85% | -0.6% |
BBIO BridgeBio Pharma, Inc. | 13,454 | $1.01M | $898,323.58 | - | -$108,980.14 | -10.82% | -0.536% |
BDN Brandywine Realty Trust | 16,416 | $47,116.82 | $43,009.92 | - | -$4,106.9 | -8.72% | -0.38% |